Eric Ostertag, Chief Executive Officer at Poseida Therapeutics, Inc. (PSTX), sold 29,608 shares at $7.02 ($208K) on 2021-10-01, disclosed to the SEC on 2021-10-05.
Open-market sale of $208k PSTX by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.02 | 9,579 | $67K | 32.4% |
| 2 | $7.02 | 9,579 | $67K | 32.4% |
| 3 | $7.02 | 10,450 | $73K | 35.3% |
| Total | $7.02 avg | 29,608 | $208K | 100% |
| Filing → |
| PSTX | SELL | 2021-11-10 | $268K | — | Filing → |
| PSTX | SELL | 2021-09-22 | $160K | — | Filing → |
| PSTX | SELL | 2021-09-15 | $163K | — | Filing → |